Effect of the French oak wood extract robuvit on markers of oxidative stress and activity of antioxidant enzymes in healthy volunteers: A pilot study

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Horvathova, Martina ^a   Orszaghova, Zuzana ^a   Laubertova, Lucia ^a,b   Vavakova, Magdalena ^a   Sabaka, Peter ^a   Rohdewald, Peter ^c   Durackova, Zdenka ^a   Muchova, Jana ^a  

^a Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^b University Teaching Hospital in Martin   (Slovakia)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYMES; OXIDATIVE STRESS; PROTEINS;

ADVANCED OXIDATION; ANTIOXIDANT CAPACITY; ANTIOXIDANT ENZYME; CU/ZN-SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE; HEALTHY VOLUNTEERS; TOTAL ANTIOXIDANT CAPACITY; TROLOX EQUIVALENT ANTIOXIDANT CAPACITIES;

ANTIOXIDANTS;

ADVANCED OXIDATION PROTEIN PRODUCT; ANTIOXIDANT; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE; LIPID PEROXIDE; PLANT EXTRACT; ROBUVIT; UNCLASSIFIED DRUG; SUPEROXIDE DISMUTASE; TANNIN;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CHEMICAL PROCEDURES; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ERYTHROCYTE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OAK; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; QUERCUS ROBUR; TROLOX EQUIVALENT ANTIOXIDANT CAPACITY METHOD; DRUG EFFECTS; METABOLISM; MIDDLE AGED; PILOT STUDY;

CATALPA LONGISSIMA; QUERCUS ROBUR;

AGED; ANTIOXIDANTS; CATALASE; FEMALE; GLUTATHIONE PEROXIDASE; HEALTHY VOLUNTEERS; HUMANS; HYDROLYZABLE TANNINS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PILOT PROJECTS; PLANT EXTRACTS; SUPEROXIDE DISMUTASE;

EID: 84930790241     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/639868     Document Type: Article

References (29)

1. W. Mayer, W. Gabler, A. Riester, and H. Korger, "On tannins compounds from the wood of chestnut and oak wood-IIs. Isolation of castalagin, vescalagin, castalin and vescaline," Liebigs Annual of Chemistry, vol. 707, pp. 177-181, 1967.
2. C. L. M. H. du Penhoat, V. M. F. Michon, S. Peng, C. Viriot, A. Scalbert, and D. Gage, "Structural elucidation of new dimeric ellagitannins from Quercus robur," Journal of the Chemical Society, no. 7, pp. 1653-1660, 1991.
3. F. Natella, G. Leoni,M.Maldini et al., "Absorption, metabolism, and effects at transcriptome level of a standardized French oak wood extract, Robuvit , in healthy volunteers: pilot study," Journal of Agricultural and Food Chemistry, vol. 62, no. 2, pp. 443-453, 2014.
4. A. Glabasnia and T. Hofmann, "Sensory-directed identification of taste-active ellagitannins in American (Quercus alba L.) and European oak wood (Quercus robur L.) and quantitative analysis in bourbon whiskey and oak-matured red wines," Journal of Agricultural and Food Chemistry, vol. 54, no. 9, pp. 3380-3390, 2006.
5. N. P. Seeram, S. M.Henning, Y. Zhang, M. Suchard, Z. Li, andD. Heber, "Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours," The Journal of Nutrition, vol. 136, no. 10, pp. 2481-2485, 2006.
6. G. Celik, A. Semiz, S. Karakurt, S.Arslan, O. Adali, andA. Sen, "A comparative study for the evaluation of two doses of ellagic acid on hepatic drug metabolizing and antioxidant enzymes in the rat," BioMed Research International, vol. 2013, Article ID 358945, 9 pages, 2013.
7. K. Kavitha, P.Thiyagarajan, J. Rathna, R.Mishra, and S. Nagini, "Chemopreventive effects of diverse dietary phytochemicals against DMBA-induced hamster buccal pouch carcinogenesis via the induction of Nrf2-mediated cytoprotective antioxidant, detoxification, andDNA repair enzymes," Biochimie, vol. 95,no. 8, pp. 1629-1639, 2013.
8. Y. S.Kim, T. Zerin, andH. Y. Song, "Antioxidant action of ellagic acid ameliorates paraquat-induced A549 cytotoxicity," Biological and Pharmaceutical Bulletin, vol. 36,no. 4, pp.609-615, 2013.
9. Z. Qiu, B. Zhou, L. Jin et al., "In vitro antioxidant and antiproliferative effects of ellagic acid and its colonic metabolite, urolithins, on human bladder cancer T24 cells," Food and Chemical Toxicology, vol. 59, pp. 428-437, 2013.
10. Y. Chung, L. Lu, M. Tsai, Y. Chen, S. Yao, and C. Hsu, "The inhibitory effect of ellagic acid on cell growth of ovarian carcinoma cells," Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 306705, 12 pages, 2013.
11. S. Umesalma, P. Nagendraprabhu, and G. Sudhandiran, "Antiproliferative and apoptotic-inducing potential of ellagic acid against 1, 2-dimethyl hydrazine-induced colon tumorigenesis in Wistar rats," Molecular and Cellular Biochemistry, vol. 388, no. 1-2, pp. 157-172, 2014.
12. L. Vanella, C. di Giacomo, R. Acquaviva et al., "Effects of ellagic acid on angiogenic factors in prostate cancer cells," Cancers, vol. 5, no. 2, pp. 726-738, 2013.
13. M. Zhao, S. Tang, J. L. Marsh, S. Shankar, and R. K. Srivastava, "Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice," Cancer Letters, vol. 337, no. 2, pp. 210-217, 2013.
14. M. R. Loizzo, A. Said, R. Tundis et al., "Antioxidant and antiproliferative activity of Diospyros lotus L. extract and isolated compounds," Plant Foods for Human Nutrition, vol. 64, no. 4, pp. 264-270, 2009.
15. M. Marín, R. M. Giner, J. L. Riós, and M. C. Recio, "Intestinal anti-inflammatory activity of ellagic acid in the acute and chronic dextrane sulphate sodium model of mice colitis," Journal of Ethnopharmacology, vol. 150, no. 3, pp. 925-934, 2013.
16. M. A. Rosillo, M. Sánchez-Hidalgo, A. Cárdeno et al., "Dietary supplementation of an ellagic acid-enriched pomegranate extract attenuates chronic colonic inflammation in rats," Pharmacological Research, vol. 66, no. 3, pp. 235-242, 2012.
17. M. Larrosa, F. A. Tomás-Barberán, and J. C. Espín, "The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using themitochondrial pathway," Journal of Nutritional Biochemistry, vol. 17, no. 9, pp. 611-625, 2006.
18. Y. Chang, W. Chen, K. Lin et al., "Novel bioactivity of ellagic acid in inhibiting human platelet activation," Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 595128, 9 pages, 2013.
19. R.Re, N. Pellegrini, A. Proteggente, A. Pannala,M. Yang, andC. Rice-Evans, "Antioxidant activity applying an improved ABTS radical cation decolorization assay," Free Radical Biology and Medicine, vol. 26, no. 9-10, pp. 1231-1237, 1999.
20. V. Witko-Sarsat, M. Friedlander, C. Capeillere-Blandin et al., "Advanced oxidation protein products as a novel marker of oxidative stress in uremia," Kidney International, vol. 49, no. 5, pp. 1304-1313, 1996.
21. H. Buss, T. P. Chan, K. B. Sluis, N. M. Domigan, and C. C. Winterbourn, "Protein carbonyl measurement by a sensitive ELISA method," Free Radical Biology and Medicine, vol. 23, no. 3, pp. 361-366, 1997.
22. M. Kalousová, J. ?Skrha, and T. Zíma, "Advanced glycation endproducts and advanced oxidation protein products in patients with diabetes mellitus," Physiological Research, vol. 51, pp. 597-604, 2002.
23. A. R. Collins, V. L. Dobson, M. Du?sinská, G. Kennedy, and R. ?St?etina, "The comet assay: what can it really tell us?" Mutation Research, vol. 375, no. 2, pp. 183-193, 1997.
24. C. M. Gedik, A. Collins, and ESCODD, "Establishing the background level of base oxidation in human lymphocyte DNA: results of an interlaboratory validation study," The FASEB Journal, vol. 19, no. 1, pp. 82-84, 2005.
25. M. El-Saadani, H. Esterbauer, M. El-Sayed, M. Goher, A. Y. Nassar, and G. Jurgens, "A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent," Journal of Lipid Research, vol. 30, no. 4, pp. 627-630, 1989.
26. H. U. Bergmeyer, Methods of Enzymatic Analysis, Volume III: Enzymes 1: Oxidoreductases, Transferases, Verlag Chemie, Weiheim, Germany, 1987.
27. D. Huang, B. Ou, M. Hampsch-Woodill, J. A. Flanagan, and R. L. Prior, "High-throughput assay of oxygen radical absorbance capacity (ORAC) using a multichannel liquid handling system coupled with a microplate fluorescence reader in 96-well format," Journal of Agricultural and FoodChemistry, vol. 50, no. 16, pp. 4437-4444, 2002.
28. I. F. F. Benzie and J. J. Strain, "The ferric reducing ability of plasma (FRAP) as a measure of 'antioxidant power': the FRAP assay," Analytical Biochemistry, vol. 239, no. 1, pp. 70-76, 1996.
29. J. C. Espín, M. Larrosa, M. T. Garciá-Conesa, and F. Tomás-Barber án, "Biological significance of urolithins, the gut microbial ellagic acid-derived metabolites: the evidence so far," Evidencebased Complementary and Alternative Medicine, vol. 2013, Article ID 270418, 15 pages, 2013.